ATRC insider trading
NasdaqGM HealthcareAtriCure, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About AtriCure, Inc.
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Company website: www.atricure.com
ATRC insider activity at a glance
FilingIQ has scored 656 insider transactions for ATRC since Mar 13, 2012. The most recent filing in our index is dated Mar 12, 2026.
Across the full history, 7 open-market purchases
and 146 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ATRC insider trades is 60.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
13F funds holding ATRC
Frequently asked
- How many insider trades does FilingIQ track for ATRC?
- FilingIQ tracks 656 Form 4 insider transactions for ATRC (AtriCure, Inc.), covering filings from Mar 13, 2012 onwards. 26 of those were filed in the last 90 days.
- Are ATRC insiders net buyers or net sellers?
- Across the full Form 4 history for ATRC, 7 transactions (1%) were open-market purchases and 146 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ATRC insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ATRC in?
- AtriCure, Inc. (ATRC) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $1.56B.
Methodology & sources
Every ATRC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.